Reassessment of the type i diabetes association of the OAS1 locus

Genes and Immunity

Volumn 10, Issue SUPPL. 1, 2009, Pages

  Qu, H Q ^a   Polychronakos, C ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Autoimmune disease; genetic susceptibility; linkage disequilibrium; OAS1; single nucleotide polymorphism; type I diabetes

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; OAS1 PROTEIN, HUMAN;

ARTICLE; CHROMOSOME 12; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM;

2',5'-OLIGOADENYLATE SYNTHETASE; CHROMOSOMES, HUMAN, PAIR 12; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 75649103606     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.95     Document Type: Article

References (12)

1. Justesen J, Hartmann R, Kjeldgaard NO. Gene structure and function of the 20-50-oligoadenylate synthetase family. Cell Mol Life Sci 2000; 57: 1593-1612.
2. Mashimo T, Lucas M, Simon-Chazottes D, Frenkiel MP, Montagutelli X, Ceccaldi PE et al. A nonsense mutation in the gene encoding 20-50-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci USA 2002; 99: 11311-11316. (Pubitemid 34920922)
3. Perelygin AA, Scherbik SV, Zhulin IB, Stockman BM, Li Y, Brinton MA. Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci USA 2002; 99: 9322-9327. (Pubitemid 34764612)
4. Lucas M, Mashimo T, Frenkiel MP, Simon-Chazottes D, Montagutelli X, Ceccaldi PE et al. Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 20-50 oligoadenylate synthetase 1b protein. Immunol Cell Biol 2003; 81: 230-236. (Pubitemid 36649270)
5. Bonnevie-Nielsen V, Field LL, Lu S, Zheng DJ, Li M, Martensen PM et al. Variation in antiviral 20,50-oligoadenylate synthetase (2050AS) enzyme activity is controlled by a singlenucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am J Hum Genet 2005; 76: 623-633. (Pubitemid 40432169)
6. Field LL, Bonnevie-Nielsen V, Pociot F, Lu S, Nielsen TB, Beck-Nielsen H. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. Diabetes 2005; 54: 1588-1591. (Pubitemid 40586694)
7. Smyth DJ, Cooper JD, Lowe CE, Nutland S, Walker NM, Clayton DG et al. No evidence for association of OAS1 with type 1 diabetes in unaffected siblings or type 1 diabetic cases. Diabetes 2006; 55: 1525-1528. (Pubitemid 44195397)
8. Tessier MC, Qu HQ, Frechette R, Bacot F, Grabs R, Taback SP et al. Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype? J Med Genet 2006; 43: 129-132. (Pubitemid 43259624)
9. Wellcome Trust Case Control Consortium. Genome-wide association study of 14000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678.
10. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39: 857-864. (Pubitemid 47018195)
11. Brown WM, Pierce JJ, Hilner JE, Perdue LH, Lohman K, Lu L et al. and the Type I Diabetes Genetics Consortium. Overview of the Rapid Response data. Genes Immun 2009; 10(Suppl 1): S5-S15.
12. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 2001; 9: 301-306. (Pubitemid 32366699)